FDA Upgrades Recall on More Than 33,000 Bottles of Blood Pressure Drugs Nationwide

The FDA said that a generic version of metoprolol was recalled because it failed to meet the agency’s criteria.

The Food and Drug Administration campus in Silver Spring, Md., on Oct. 14, 2015. Andrew Harnik / AP Photo

The Food and Drug Administration on July 8 upgraded a recall of a generic version of blood pressure medication metoprolol to its second-highest level because it failed to meet the FDA’s own criteria.

The recall notice encompasses metoprolol succinate extended-release tablets in 25 milligram doses in 100-count and 500-count bottles. India-based Granules Pharmaceuticals Inc., the manufacturer, voluntarily recalled the medication, which is a beta-blocker used to treat high blood pressure, heart failure, and angina, or chest pain.